Signature Wealth Management Partners’s ADMA Biologics ADMA Stock Holding History

Signature Wealth Management Partners’s Portfolio ADMA Stock Details ADMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,116	Closed	-$202K	–	103
2024 Q3	$202K	Sell	10,116 -84	-0.8%	-$1.31K	0.15%	101
2024 Q2	$114K	Hold	10,200	–	–	0.09%	103
2024 Q1	$67.3K	Hold	10,200	–	–	0.05%	100
2023 Q4	$46.1K	Hold	10,200	–	–	0.04%	94
2023 Q3	$36.5K	Hold	10,200	–	–	0.04%	91
2023 Q2	$37.6K	Hold	10,200	–	–	0.03%	95
2023 Q1	$33.8K	Hold	10,200	–	–	0.03%	105
2022 Q4	$39.6K	Hold	10,200	–	–	0.04%	98
2022 Q3	$25K	Sell	10,200 -200	-2%	-$480	0.03%	99
2022 Q2	$21K	Hold	10,400	–	–	0.02%	105
2022 Q1	$19K	Hold	10,400	–	–	0.02%	113
2021 Q4	$15K	Sell	10,400 -100	-1%	-$131	0.01%	110
2021 Q3	$12K	Hold	10,500	–	–	0.01%	111
2021 Q2	$17K	Hold	10,500	–	–	0.02%	108
2021 Q1	$18K	Buy	+10,500	New	+$24K	0.02%	103

Other funds holding ADMA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Signature Wealth Management Partners's ADMA Position: Q4 2024 in Review

Signature Wealth Management Partners sold out of ADMA Biologics (ADMA) in Q4 2024, closing a stake of 10,116 shares — an estimated $202K sold.

Signature Wealth Management Partners first reported a position in ADMA in Q1 2021 and held it in 15 quarters. The position peaked at $202K in Q3 2024. 322 funds tracked by Wall St. Rank hold ADMA as of Q4 2024.

Signature Wealth Management Partners reported no remaining ADMA Biologics position as of Q4 2024 after selling out during the quarter.
Signature Wealth Management Partners sold 10,116 ADMA Biologics shares in Q4 2024, an estimated $202K.
Signature Wealth Management Partners first reported a position in ADMA Biologics in Q1 2021 and held it in 15 quarters.
Signature Wealth Management Partners's ADMA Biologics position peaked at $202K in Q3 2024.
322 funds tracked by Wall St. Rank held ADMA Biologics as of Q4 2024.

Based on Signature Wealth Management Partners's 13F filing for Q4 2024, filed 23 Jan 2025.